Zonisamide’s Efficacy and Safety on Parkinson’s Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review

Zonisamide’s Efficacy and Safety on Parkinson’s Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review
Biomed Res Int. 2022 Sep 12;2022:4817488. doi: 10.1155/2022/4817488. eCollection 2022.ABSTRACTOBJECTIVE: Clinical data has recently shown an association between Parkinson's disease (PD), Dementia with Lewy bodies (DLB), and zonisamide. The purpose of this study was to thoroughly evaluate the efficacy and safety of zonisamide in PD and DLB.METHODS: Pubmed, the Cochrane Library, Web of Science, and Embase databases were searched for ... read more
Source: PubMedPublished on 2022-09-22By Linghui Kong